AHR and neoplasm: Another target of KYNA is the aryl hydrocarbon receptor (AHR), which is considered a xenobiotic receptor [27], and its activation is associated with the suppression of cellular immune response favoring carcinogenesis and tumor outgrowth [25, 27].